KDR
Receptor domena kinazne insercije (KDR, tip IV receptora tirozin-kinaza), znan i kao receptor 2 vaskularnog endotelnog faktora rasta (VEGFR-2) jest VEGF-receptor koji je kod ljudi kodiran genom KDR sa hromosoma 4. Označava se i kao CD309 (klaster diferencijacije 309) i kao Flk1 (eng. Fetal Liver Kinase 1 = fetusna jetrena kinaza).
Aminokiselinska sekvenca
Dužina polipeptidnog lanca je 1.356 aminokiselina, а molekulska težina 151.527 Da.[5]
| 10 | 20 | 30 | 40 | 50 | ||||
|---|---|---|---|---|---|---|---|---|
| MQSKVLLAVA | LWLCVETRAA | SVGLPSVSLD | LPRLSIQKDI | LTIKANTTLQ | ||||
| ITCRGQRDLD | WLWPNNQSGS | EQRVEVTECS | DGLFCKTLTI | PKVIGNDTGA | ||||
| YKCFYRETDL | ASVIYVYVQD | YRSPFIASVS | DQHGVVYITE | NKNKTVVIPC | ||||
| LGSISNLNVS | LCARYPEKRF | VPDGNRISWD | SKKGFTIPSY | MISYAGMVFC | ||||
| EAKINDESYQ | SIMYIVVVVG | YRIYDVVLSP | SHGIELSVGE | KLVLNCTART | ||||
| ELNVGIDFNW | EYPSSKHQHK | KLVNRDLKTQ | SGSEMKKFLS | TLTIDGVTRS | ||||
| DQGLYTCAAS | SGLMTKKNST | FVRVHEKPFV | AFGSGMESLV | EATVGERVRI | ||||
| PAKYLGYPPP | EIKWYKNGIP | LESNHTIKAG | HVLTIMEVSE | RDTGNYTVIL | ||||
| TNPISKEKQS | HVVSLVVYVP | PQIGEKSLIS | PVDSYQYGTT | QTLTCTVYAI | ||||
| PPPHHIHWYW | QLEEECANEP | SQAVSVTNPY | PCEEWRSVED | FQGGNKIEVN | ||||
| KNQFALIEGK | NKTVSTLVIQ | AANVSALYKC | EAVNKVGRGE | RVISFHVTRG | ||||
| PEITLQPDMQ | PTEQESVSLW | CTADRSTFEN | LTWYKLGPQP | LPIHVGELPT | ||||
| PVCKNLDTLW | KLNATMFSNS | TNDILIMELK | NASLQDQGDY | VCLAQDRKTK | ||||
| KRHCVVRQLT | VLERVAPTIT | GNLENQTTSI | GESIEVSCTA | SGNPPPQIMW | ||||
| FKDNETLVED | SGIVLKDGNR | NLTIRRVRKE | DEGLYTCQAC | SVLGCAKVEA | ||||
| FFIIEGAQEK | TNLEIIILVG | TAVIAMFFWL | LLVIILRTVK | RANGGELKTG | ||||
| YLSIVMDPDE | LPLDEHCERL | PYDASKWEFP | RDRLKLGKPL | GRGAFGQVIE | ||||
| ADAFGIDKTA | TCRTVAVKML | KEGATHSEHR | ALMSELKILI | HIGHHLNVVN | ||||
| LLGACTKPGG | PLMVIVEFCK | FGNLSTYLRS | KRNEFVPYKT | KGARFRQGKD | ||||
| YVGAIPVDLK | RRLDSITSSQ | SSASSGFVEE | KSLSDVEEEE | APEDLYKDFL | ||||
| TLEHLICYSF | QVAKGMEFLA | SRKCIHRDLA | ARNILLSEKN | VVKICDFGLA | ||||
| RDIYKDPDYV | RKGDARLPLK | WMAPETIFDR | VYTIQSDVWS | FGVLLWEIFS | ||||
| LGASPYPGVK | IDEEFCRRLK | EGTRMRAPDY | TTPEMYQTML | DCWHGEPSQR | ||||
| PTFSELVEHL | GNLLQANAQQ | DGKDYIVLPI | SETLSMEEDS | GLSLPTSPVS | ||||
| CMEEEEVCDP | KFHYDNTAGI | SQYLQNSKRK | SRPVSVKTFE | DIPLEEPEVK | ||||
| VIPDDNQTDS | GMVLASEELK | TLEDRTKLSP | SFGGMVPSKS | RESVASEGSN | ||||
| QTSGYQSGYH | SDDTDTTVYS | SEEAELLKLI | EIGVQTGSTA | QILQPDSGTT | ||||
| LSSPPV |
Funkcija
Genetička varijanta Q472H zametne linije KDR utiče na fosforilaciju VEGFR-2 i utvrđeno je da je povezana sa gustoćom mikrovaskularnih sudova u karcinomu pluća nemalih ćelija (NSCLC).[6]
Interakcije
Pokazalo se da receptor domen insercije kinaze ima interakcije sa SHC2,[7] aneksinom A5[8] i SHC1.[9][10]
Također pogledajte
Reference
- ^ a b c GRCh38: Ensembl release 89: ENSG00000128052 - Ensembl, maj 2017
- ^ a b c GRCm38: Ensembl release 89: ENSMUSG00000062960 - Ensembl, maj 2017
- ^ "Human PubMed Reference:". National Center for Biotechnology Information, U.S. National Library of Medicine.
- ^ "Mouse PubMed Reference:". National Center for Biotechnology Information, U.S. National Library of Medicine.
- ^ "UniProt, P35968" (jezik: engleski). Pristupljeno 29. 10. 2021.
- ^ Glubb DM, Cerri E, Giese A, Zhang W, Mirza O, Thompson EE, Chen P, Das S, Jassem J, Rzyman W, Lingen MW, Salgia R, Hirsch FR, Dziadziuszko R, Ballmer-Hofer K, Innocenti F (august 2011). "Novel functional germline variants in the VEGF receptor 2 gene and their effect on gene expression and microvessel density in lung cancer". Clinical Cancer Research. 17 (16): 5257–67. doi:10.1158/1078-0432.CCR-11-0379. PMC 3156871. PMID 21712447.
- ^ Warner AJ, Lopez-Dee J, Knight EL, Feramisco JR, Prigent SA (april 2000). "The Shc-related adaptor protein, Sck, forms a complex with the vascular-endothelial-growth-factor receptor KDR in transfected cells". The Biochemical Journal. 347 (Pt 2): 501–9. doi:10.1042/0264-6021:3470501. PMC 1220983. PMID 10749680.
- ^ Wen Y, Edelman JL, Kang T, Sachs G (maj 1999). "Lipocortin V may function as a signaling protein for vascular endothelial growth factor receptor-2/Flk-1". Biochemical and Biophysical Research Communications. 258 (3): 713–21. doi:10.1006/bbrc.1999.0678. PMID 10329451.
- ^ Zanetti A, Lampugnani MG, Balconi G, Breviario F, Corada M, Lanfrancone L, Dejana E (april 2002). "Vascular endothelial growth factor induces SHC association with vascular endothelial cadherin: a potential feedback mechanism to control vascular endothelial growth factor receptor-2 signaling". Arteriosclerosis, Thrombosis, and Vascular Biology. 22 (4): 617–22. doi:10.1161/01.ATV.0000012268.84961.AD. PMID 11950700.
- ^ D'Angelo G, Martini JF, Iiri T, Fantl WJ, Martial J, Weiner RI (maj 1999). "16K human prolactin inhibits vascular endothelial growth factor-induced activation of Ras in capillary endothelial cells". Molecular Endocrinology. 13 (5): 692–704. doi:10.1210/mend.13.5.0280. PMID 10319320.
Dopunska literatura
- Holmes K, Roberts OL, Thomas AM, Cross MJ (oktobar 2007). "Vascular endothelial growth factor receptor-2: structure, function, intracellular signalling and therapeutic inhibition". Cellular Signalling. 19 (10): 2003–12. doi:10.1016/j.cellsig.2007.05.013. PMID 17658244.
- Petrova TV, Makinen T, Alitalo K (novembar 1999). "Signaling via vascular endothelial growth factor receptors". Experimental Cell Research. 253 (1): 117–30. doi:10.1006/excr.1999.4707. PMID 10579917.
- Wang J, Fu X, Jiang C, Yu L, Wang M, Han W, Liu L, Wang J (maj 2014). "Bone marrow mononuclear cell transplantation promotes therapeutic angiogenesis via upregulation of the VEGF-VEGFR2 signaling pathway in a rat model of vascular dementia". Behavioural Brain Research. 265: 171–80. doi:10.1016/j.bbr.2014.02.033. PMC 4000455. PMID 24589546.
- Sato Y, Kanno S, Oda N, Abe M, Ito M, Shitara K, Shibuya M (maj 2000). "Properties of two VEGF receptors, Flt-1 and KDR, in signal transduction". Annals of the New York Academy of Sciences. 902 (1): 201–5, discussion 205–7. Bibcode:2000NYASA.902..201S. doi:10.1111/j.1749-6632.2000.tb06314.x. PMID 10865839. S2CID 11488629.
- Zachary I, Gliki G (februar 2001). "Signaling transduction mechanisms mediating biological actions of the vascular endothelial growth factor family". Cardiovascular Research. 49 (3): 568–81. doi:10.1016/S0008-6363(00)00268-6. PMID 11166270.
- Vené R, Benelli R, Noonan DM, Albini A (2001). "HIV-Tat dependent chemotaxis and invasion, key aspects of tat mediated pathogenesis". Clinical & Experimental Metastasis. 18 (7): 533–8. doi:10.1023/A:1011991906685. PMID 11688957. S2CID 24787929.
- Lenton K (2003). "VEGFR-2 (KDR/Flk-1)". Journal of Biological Regulators and Homeostatic Agents. 16 (3): 227–32. PMID 12456025.
- Matsumoto T, Mugishima H (juni 2006). "Signal transduction via vascular endothelial growth factor (VEGF) receptors and their roles in atherogenesis". Journal of Atherosclerosis and Thrombosis. 13 (3): 130–5. doi:10.5551/jat.13.130. PMID 16835467.
Vanjski linkovi
- Kinase insert domain receptor na US National Library of Medicine Medical Subject Headings (MeSH)
- P35968
Ovaj članak uključuje tekst iz Nacionalne medicinske biblioteke Sjedinjenih Država, koji je u javnom vlasništvu.
Content Disclaimer
Informasi ini disarikan dari Wikipedia dan disajikan kembali untuk tujuan edukasi. Konten tersedia di bawah lisensi CC BY-SA 3.0. Kami tidak bertanggung jawab atas ketidakakuratan data yang bersumber dari kontribusi publik tersebut.
- The information displayed on this website is sourced in part or in whole from Wikipedia and has been adapted for the purpose of restating it. We strive to provide accurate and relevant information, however:
- There is no guarantee of absolute accuracy. Wikipedia is an open, collaborative project that can be edited by anyone, so information is subject to change.
- It is not intended to constitute professional advice. The content displayed is for informational and educational purposes only. For important decisions (e.g., medical, legal, or financial), please consult a professional.
- Content copyright. Wikipedia is licensed under the Creative Commons Attribution-ShareAlike License (CC BY-SA). This means that content may be reused with appropriate attribution and shared under a similar license.
- Responsible use. Any risk arising from the use of information from this website is entirely the responsibility of the user.









